XML 39 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Equity and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 29, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Roll Forward A summary of stock option activity during the thirteen weeks ended March 29, 2026 was as follows:
NUMBER OF OPTIONSWEIGHTED AVERAGE
EXERCISE PRICE PER SHARE
AGGREGATE INTRINSIC VALUE
(in thousands)
WEIGHTED AVERAGE
REMAINING CONTRACTUAL LIFE
(in years)
Outstanding, December 28, 2025
3,577,374 $10.15 $20,614 3.2
Exercised(9,051)$9.77 
Outstanding, March 29, 2026
3,568,323 $10.16 $3,993 2.8
Exercisable, March 29, 2026
3,568,323 $10.16 $3,993 2.8
Schedule of Fair Value Non-vested Options at Grant Dates
A summary of the non-vested stock option activity during the thirteen weeks ended March 29, 2026 is as follows:
NUMBER OF OPTIONSWEIGHTED AVERAGE GRANT DATE FAIR VALUE PER SHARE
Nonvested, December 28, 2025
3,946 $5.22 
Vested (3,946)$5.22 
Nonvested, March 29, 2026
— $— 
Schedule of Nonvested Restricted Stock Units Activity
A summary of the Company’s RSU activity during the thirteen weeks ended March 29, 2026 is as follows:
RESTRICTED STOCK UNITSWEIGHTED AVERAGE GRANT DATE FAIR VALUE PER SHAREAGGREGATE INTRINSIC VALUE
(in thousands)
Outstanding, December 28, 2025
2,010,917 $17.60 $31,994 
Granted 1,005,581 $12.48 
Forfeited(79,553)$16.09 
Vested (484,126)$18.61 
Outstanding, March 29, 2026
2,452,819 $15.35 $25,289 
Schedule of Unrecognized Stock-based Compensation Expense
The following represents unrecognized stock-based compensation expense and the remaining weighted average vesting period as of March 29, 2026:
UNRECOGNIZED STOCK-BASED COMPENSATION EXPENSE
(in thousands)
REMAINING WEIGHTED AVERAGE
RECOGNITION PERIOD
(in years)
Restricted stock units $33,737 2.8